Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Biomed Anal ; 58: 136-40, 2012 Jan 25.
Article in English | MEDLINE | ID: mdl-22000073

ABSTRACT

A novel, sensitive, stability indicating simultaneous dual wavelength reverse phase UV-HPLC method has been developed for the quantitative determination of potential impurities of fampridine active pharmaceutical ingredient. Efficient chromatographic separation was achieved on a C18 stationary phase in gradient mode and quantitation by ultraviolet dual wavelength detection. The method was validated according to ICH guidelines with respect to specificity, precision, linearity and accuracy. Regression analysis showed correlation coefficient value greater than 0.999 for fampridine and its seven impurities. Detection limit as low as 0.003% was achieved for fampridine N-oxide and 0.01% for other impurities. Accuracy of the method was established based on the recovery obtained between 93.3% and 110.0% for all impurities. The method was found to be specific, selective to the degradation products and robust. Peak purity analysis by PDA detector confirmed the specificity of the method. Major degradation of the drug substance was found to occur under oxidative stress conditions to form fampridine N-oxide.


Subject(s)
4-Aminopyridine/chemistry , Chromatography, High Pressure Liquid/methods , Drug Contamination , Chromatography, Reverse-Phase/methods , Drug Stability , Hydrogen-Ion Concentration , Hydrolysis , Oxidation-Reduction , Regression Analysis , Sensitivity and Specificity , Ultraviolet Rays
2.
J Pharm Biomed Anal ; 61: 165-75, 2012 Mar 05.
Article in English | MEDLINE | ID: mdl-22178334

ABSTRACT

A novel, sensitive, selective and stability indicating LC-UV method was developed for the determination of potential impurities of eslicarbazepine acetate. High performance liquid chromatographic investigation of eslicarbazepine acetate laboratory sample revealed the presence of several impurities. Three impurities were characterized rapidly and four impurities were found to be unknown. The unknown impurities were identified by liquid chromatography coupled with electrospray ionization, ion trap mass spectrometry (LC/ESI-IT/MS/MS). Structural confirmation of these impurities was unambiguously carried out by synthesis followed by characterization using nuclear magnetic resonance spectroscopy (NMR), infrared spectroscopy (FT-IR) and mass spectrometry (MS). Based on the spectroscopic, spectrometric and elemental analysis data unknown impurities were characterized as 5-acetyl-5,11-dihydro-10H-dibenzo [b,f]azepin-10-one, N-acetyl-5H-dibenzo[b,f]azepine-5-carboxamide, 5-acetyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate and 5-acetyl-5H-dibenzo[b,f]azepin-10-yl acetate. The newly developed LC-UV method was validated according to ICH guidelines considering eleven potential impurities and four new impurities to demonstrate specificity, precision, linearity, accuracy and stability indicating nature of the method. The newly developed method was found to be highly efficient, selective, sensitive and stability indicating. A plausible pathway for the formation of four new impurities is proposed.


Subject(s)
Dibenzazepines/chemistry , Drug Contamination , Magnetic Resonance Spectroscopy/methods , Spectrometry, Mass, Electrospray Ionization/methods , Tandem Mass Spectrometry/methods , Chromatography, High Pressure Liquid/methods , Chromatography, High Pressure Liquid/standards , Chromatography, Liquid/methods , Chromatography, Liquid/standards , Drug Stability , Magnetic Resonance Spectroscopy/standards , Mass Spectrometry/methods , Mass Spectrometry/standards , Spectrometry, Mass, Electrospray Ionization/standards , Spectrophotometry, Ultraviolet/methods , Spectrophotometry, Ultraviolet/standards , Spectroscopy, Fourier Transform Infrared/methods , Spectroscopy, Fourier Transform Infrared/standards , Tandem Mass Spectrometry/standards
3.
J Pharm Biomed Anal ; 60: 86-90, 2012 Feb 23.
Article in English | MEDLINE | ID: mdl-22115882

ABSTRACT

A sensitive, stability indicating reverse phase UV-HPLC method has been developed for the quantitative determination of potential impurities of niacinamide active pharmaceutical ingredient. Efficient chromatographic separation was achieved on C18 stationary phase in isocratic mode using simple mobile phase. Forced degradation study confirmed that the newly developed method was specific and selective to the degradation products. Major degradation of the drug substance was found to occur under oxidative stress conditions to form niacinamide N-oxide. The method was validated according to ICH guidelines with respect to specificity, precision, linearity and accuracy. Regression analysis showed correlation coefficient value greater than 0.999 for niacinamide and its six impurities. Detection limit of impurities was in the range of 0.003-0.005% indicating the high sensitivity of the newly developed method. Accuracy of the method was established based on the recovery obtained between 93.3% and 113.3% for all impurities.


Subject(s)
Chromatography, High Pressure Liquid/methods , Chromatography, Reverse-Phase/methods , Drug Contamination/statistics & numerical data , Drug Stability , Niacinamide/analogs & derivatives , Niacinamide/analysis , Chromatography, High Pressure Liquid/statistics & numerical data , Chromatography, Reverse-Phase/statistics & numerical data , Limit of Detection , Niacinamide/chemistry , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL
...